(Q33815691)

English

Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

author name string

K Tillisch

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Labus

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Nam

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Bueller

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S Smith

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Suyenobu

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Siffert

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J McKelvy

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

B Naliboff

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

E Mayer

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

360-367

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Spinal cord mechanisms mediating behavioral hyperalgesia induced by neurokinin-1 tachykinin receptor activation in the rostral ventromedial medulla

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

What is the value of human FMRI in CNS drug development?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: a network analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Neurokinin 1 receptor antagonism as a possible therapy for alcoholism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Emerging drugs for irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Inflammatory bowel disease and irritable bowel syndrome: separate or unified?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Peptides that fine-tune the serotonin system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

The positive and negative affect schedule (PANAS): construct validity, measurement properties and normative data in a large non-clinical sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

The brain-gut axis in irritable bowel syndrome--clinical aspects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Irritable bowel syndrome, anxiety, and depression: what are the links?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Tachykinin receptors in the gut: physiological and pathological implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Lanepitant, an NK-1 antagonist, in migraine prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Neuroanatomical localisation of Substance P in the CNS and sensory neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Study of the analgesic effect of lanepitant in patients with osteoarthritis pain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Evidence for two distinct perceptual alterations in irritable bowel syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

The hospital anxiety and depression scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4073664

4 July 2018

Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Prevalence of irritable bowel syndrome among university students: the roles of worry, neuroticism, anxiety sensitivity and visceral anxiety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

A validated network of effective amygdala connectivity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

NK1 receptor antagonism and the neural processing of emotional information in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04958.X

21 January 2018

Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release

1 reference

https://pubmed.ncbi.nlm.nih.gov/22221140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22221140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The short-form McGill Pain Questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/22221140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22221140

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2036.2011.04958.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33815691&oldid=1533689048"